- Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
- SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION
- SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
- SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
- Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024
More ▼
Key statistics
On Tuesday, Sera Prognostics Inc (SERA:NMQ) closed at 7.95, -35.65% below its 52-week high of 12.36, set on May 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.58 |
---|---|
High | 8.07 |
Low | 7.56 |
Bid | 6.00 |
Offer | 8.75 |
Previous close | 7.62 |
Average volume | 149.10k |
---|---|
Shares outstanding | 32.65m |
Free float | 27.10m |
P/E (TTM) | -- |
Market cap | 248.82m USD |
EPS (TTM) | -1.07 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 21:00 BST.
More ▼